Clinical significance of immune-related antigen CD58 in gliomas and analysis of its potential core related gene clusters
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Hunan Province Health Commission (20230451)
- Hunan Province Health Commission (20201191)
- Health Commission of Henan Province
- National Natural Science Foundation of China (82,160,554)
- National Natural Science Foundation of China (81,560,414)
This publication has 46 references indexed in Scilit:
- The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approachesImmunity, Inflammation and Disease, 2023
- Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platformiMeta, 2022
- Clinical practice guidelines for the management of adult diffuse gliomasCancer Letters, 2021
- Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trialCancer Immunology, Immunotherapy, 2018
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networksBioSystems, 2015
- Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccineCancer Immunology, Immunotherapy, 2012
- T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCRCancer Letters, 2005
- Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomasActa Neuropathologica, 1997
- Expression of leucocyte adhesion molecules at the human blood‐brain barrier (BBB)Journal of Neuroscience Research, 1992
- Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomasJournal of Neuroimmunology, 1990